XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Statutory Reserve [Member]
Retained Earnings [Member]
Total
Balance at beginning of period at Dec. 31, 2020 $ 5,596 $ 39,766,978 $ 798,290 $ 6,241 $ 351,370 $ 40,928,475
Balance at beginning of period, shares at Dec. 31, 2020 5,596,234          
Stock issued to employees $ 5 8,905 8,910
Stock issued to employees, shares 4,500          
Stock issued to consultants $ 15 29,685 29,700
Stock issued to consultants, shares 15,000          
Forign currency translation loss (484,738) (484,738)
Net loss (8,505,696) (8,505,696)
Issuance of common stock $ 1,114 2,759,859 2,760,973
Issuance of common stock, shares 1,114,508          
De-registration and liquidation of Nova Macau (6,241) 6,241
Balance at end of period at Sep. 30, 2021 $ 6,730 42,565,427 313,552 (8,148,085) 34,737,624
Balance at end of period, shares at Sep. 30, 2021 6,730,242          
Balance at beginning of period at Jun. 30, 2021 $ 5,609 39,792,705 405,526 (6,751,453) 33,452,387
Balance at beginning of period, shares at Jun. 30, 2021 5,609,234          
Stock issued to employees $ 2 2,968   2,970
Stock issued to employees, shares 1,500          
Stock issued to consultants $ 5 9,895 9,900
Stock issued to consultants, shares 5,000          
Forign currency translation loss (91,974)   (91,974)
Net loss   (1,396,632) (1,396,632)
Issuance of common stock $ 1,114 2,759,859   2,760,973
Issuance of common stock, shares 1,114,508          
Balance at end of period at Sep. 30, 2021 $ 6,730 42,565,427 313,552 (8,148,085) 34,737,624
Balance at end of period, shares at Sep. 30, 2021 6,730,242          
Balance at beginning of period at Dec. 31, 2021 $ 6,837 42,660,383 381,850 (19,604,882) 23,444,188
Balance at beginning of period, shares at Dec. 31, 2021 6,836,742          
Stock issued to employees $ 5 9,895 9,900
Stock issued to employees, shares 4,500          
Stock issued to consultants $ 109 476,871 476,980
Stock issued to consultants, shares 109,807          
Forign currency translation loss (1,187,904) (1,187,904)
Net loss (8,302,546) (8,302,546)
Balance at end of period at Sep. 30, 2022 $ 6,951 43,147,149 (806,054) (27,907,428) 14,440,618
Balance at end of period, shares at Sep. 30, 2022 6,951,049          
Balance at beginning of period at Jun. 30, 2022 $ 6,892 42,974,288 87,258 (26,194,436) 16,874,002
Balance at beginning of period, shares at Jun. 30, 2022 6,891,313          
Stock issued to employees $ 2 3,298   3,300
Stock issued to employees, shares 1,500          
Stock issued to consultants $ 57 169,563 169,620
Stock issued to consultants, shares 58,236          
Forign currency translation loss (893,312)   (893,312)
Net loss   (1,712,992) (1,712,992)
Balance at end of period at Sep. 30, 2022 $ 6,951 $ 43,147,149 $ (806,054) $ (27,907,428) $ 14,440,618
Balance at end of period, shares at Sep. 30, 2022 6,951,049